ARPA-H Launches the CUREIT project to Develop New Tools to Strengthen the Immune System and Save Lives

The Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services (HHS) is announcing up to $24 million for Curing the Uncurable via RNA-Encoded Immunogene Tuning (CUREIT), a project that aims to train the immune system to better fight cancer and other diseases with the goal of developing generalizable mRNA platforms to treat diverse diseases and save lives.

“CUREIT aims to develop entirely new tools and methods to improve therapies so that fewer families experience loss from cancer,” said ARPA-H Mission Office Director Amy Jenkins, PhD. “The advances in programming immune cell function that may result from CUREIT could also be broadly applied to many other health conditions affecting Americans.”